165 related articles for article (PubMed ID: 16433197)
1. The emerging role of oxaliplatin in the treatment of gastric cancer.
Zaniboni A; Meriggi F
J Chemother; 2005 Dec; 17(6):656-62. PubMed ID: 16433197
[TBL] [Abstract][Full Text] [Related]
2. Platinum compounds in the treatment of advanced breast cancer.
Martín M
Clin Breast Cancer; 2001 Oct; 2(3):190-208; discussion 209. PubMed ID: 11899413
[TBL] [Abstract][Full Text] [Related]
3. Toxicity of platinum compounds.
Hartmann JT; Lipp HP
Expert Opin Pharmacother; 2003 Jun; 4(6):889-901. PubMed ID: 12783586
[TBL] [Abstract][Full Text] [Related]
4. Ongoing and unsaid on oxaliplatin: the hope.
Cvitkovic E
Br J Cancer; 1998 Jun; 77 Suppl 4(Suppl 4):8-11. PubMed ID: 9647613
[TBL] [Abstract][Full Text] [Related]
5. Comparative effectiveness and safety between oxaliplatin-based and cisplatin-based therapy in advanced gastric cancer: A meta-analysis of randomized controlled trials.
Huang J; Zhao Y; Xu Y; Zhu Y; Huang J; Liu Y; Zhao L; Li Z; Liu H; Wang QL; Qi X
Oncotarget; 2016 Jun; 7(23):34824-31. PubMed ID: 27166187
[TBL] [Abstract][Full Text] [Related]
6. Gastric cancer. Treatment of advanced disease and new drugs.
Caponigro F; Facchini G; Nasti G; Iaffaioli RV
Front Biosci; 2005 Sep; 10():3122-6. PubMed ID: 15970566
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of Combination Chemotherapy Using a Novel Oral Chemotherapeutic Agent, TAS-102, with Oxaliplatin on Human Colorectal and Gastric Cancer Xenografts.
Nukatsuka M; Nakagawa F; Takechi T
Anticancer Res; 2015 Sep; 35(9):4605-15. PubMed ID: 26254349
[TBL] [Abstract][Full Text] [Related]
8. Comparison between DCF (Docetaxel, Cisplatin and 5-Fluorouracil) and modified EOX (Epirubicin, Oxaliplatin and Capecitabine) as palliative first-line chemotherapy for adenocarcinoma of the upper gastrointestinal tract.
Ilhan-Mutlu A; Preusser M; Schoppmann SF; Asari R; Ba-Ssalamah A; Schwameis K; Pluschnig U; Birner P; Püspök A; Zacherl J; Hejna M
Anticancer Res; 2013 Aug; 33(8):3455-9. PubMed ID: 23898119
[TBL] [Abstract][Full Text] [Related]
9. A phase II study of docetaxel and oxaliplatin combination in recurrent gastric cancer patients after fluoropyrimidine and/or cisplatin adjuvant treatment: a Korean Cancer Study Group Protocol ST06-02.
Choi YH; Oh SC; Kim JS; Nam SH; Kim BS; Cho SH; Chung IJ; Song EK; Yim CY; Baek JH; Jeung HC; Hong YS; Yang SH; Kang HJ
Cancer Chemother Pharmacol; 2012 Nov; 70(5):665-72. PubMed ID: 22926638
[TBL] [Abstract][Full Text] [Related]
10. Review of oxaliplatin: an active platinum agent in colorectal cancer.
Cassidy J
Int J Clin Pract; 2000; 54(6):399-402. PubMed ID: 11092115
[TBL] [Abstract][Full Text] [Related]
11. Oxaliplatin-based chemotherapy in the management of colorectal cancer.
Capdevila J; Elez E; Peralta S; Macarulla T; Ramos FJ; Tabernero J
Expert Rev Anticancer Ther; 2008 Aug; 8(8):1223-36. PubMed ID: 18699761
[TBL] [Abstract][Full Text] [Related]
12. Capecitabine and oxaliplatin (XELOX) is safe and effective in patients with advanced gastric cancer.
Quek R; Lim WT; Foo KF; Koo WH; A-Manaf A; Toh HC
Acta Oncol; 2007; 46(7):1032-4. PubMed ID: 17917832
[No Abstract] [Full Text] [Related]
13. Oxaliplatin in tumors other than colorectal cancer.
Lorusso PM
Oncology (Williston Park); 2000 Dec; 14(12 Suppl 11):33-7. PubMed ID: 11204661
[TBL] [Abstract][Full Text] [Related]
14. Oxaliplatin: available data in non-colorectal gastrointestinal malignancies.
Bécouarn Y; Agostini C; Trufflandier N; Boulanger V
Crit Rev Oncol Hematol; 2001 Dec; 40(3):265-72. PubMed ID: 11738949
[TBL] [Abstract][Full Text] [Related]
15. [Oxaliplatin: a first DACH-platinum in oncology].
Laadem A; Cvitkovic E
Bull Cancer; 2001 Aug; 88 Spec No():S9-13. PubMed ID: 11567908
[TBL] [Abstract][Full Text] [Related]
16. Complete pathologic response with combination oxaliplatin and 5-fluorouracil chemotherapy in an older patient with advanced gastric cancer.
Amini A; Sanati H
Anticancer Drugs; 2011 Nov; 22(10):1024-6. PubMed ID: 21822120
[TBL] [Abstract][Full Text] [Related]
17. Oxaliplatin: mechanism of action and antineoplastic activity.
Raymond E; Faivre S; Woynarowski JM; Chaney SG
Semin Oncol; 1998 Apr; 25(2 Suppl 5):4-12. PubMed ID: 9609103
[TBL] [Abstract][Full Text] [Related]
18. Oxaliplatin: a novel platinum analog with activity in colorectal cancer.
Berg D
Oncol Nurs Forum; 2003; 30(6):957-66. PubMed ID: 14603353
[TBL] [Abstract][Full Text] [Related]
19. Chemotherapy of metastatic colorectal cancer: fluorouracil plus folinic acid and irinotecan or oxaliplatin.
Prescrire Int; 2005 Dec; 14(80):230-3. PubMed ID: 16400749
[TBL] [Abstract][Full Text] [Related]
20. [Role and value of oxaliplatin in metastatic colorectal cancers].
Louvet C; de Gramont A
Rev Med Interne; 1997; 18 Suppl 4():368s-371s. PubMed ID: 9365714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
